布地奈德联合咖啡因预防早产儿支气管肺发育不良的疗效研究

doi:10.11852/zgetbjzz2018-0947

中国儿童保健杂志 ›› 2019, Vol. 27 ›› Issue (10): 1124-1127.DOI: 10.11852/zgetbjzz2018-0947

布地奈德联合咖啡因预防早产儿支气管肺发育不良的疗效研究

陈萌萌, 温晓红, 黄金华, 孙亚伟

合肥市第一人民医院南区滨湖医院儿科,安徽合肥 230061

收稿日期:2018-09-19 发布日期:2019-10-10 出版日期:2019-10-10
通讯作者: 温晓红,E-mail:wenxiaohong2007@163.com
作者简介:陈萌萌(1987-),女,硕士研究生,住院医师,主要研究方向为早产儿支气管肺发育不良的防治。
基金资助:
安徽省科技攻关项目(1604a0802093);合肥市科技局自主创新政策“借转补”资助项目(2014-3-2)

Clinical efficacy of budesonide combined with caffeine citrate for preventing bronchopulmonary dysplasia in preterm infants

CHEN Meng-Meng, WEN Xiao-hong, HUANG Jin-hua, SUN Ya-wei

Department of Pediatrics,Binhu Hospital of Southern District,the First Hospital of Hefei City,Hefei,Anhui 230061,China

Received:2018-09-19 Online:2019-10-10 Published:2019-10-10
Contact: WEN Xiao-hong,E-mail:wenxiaohong2007@163.com

摘要/Abstract

摘要： 目的分析早期联合使用吸入性布地奈德和枸橼酸咖啡因预防极低出生体重早产儿支气管肺发育不良(BPD)的临床疗效,以期为BPD的防治提供参考。方法 2014年10月-2017年10月在合肥市第一人民医院南区滨湖医院选取胎龄<32 周且出生体重低于1 500 g的极低出生体重儿 60例,随机分成咖啡因+布地奈德组(n=30例)和咖啡因组(n=30)。比较两组呼吸机使用时间、撤机后吸氧时间、住院时间、病死率、BPD 发生率及常见并发症的发生率。结果咖啡因+布地奈德组呼吸机使用时间和吸氧时间明显短于咖啡因组(t=2.09,Z=2.36,P<0.05),咖啡因+布地奈德组的BPD发生率较咖啡因组有所降低,但差异无统计学意义(P>0.05),两组住院时间及常见并发症的发生率差异无统计学意义(P>0.05)。结论早期联合使用吸入性布地奈德和枸橼酸咖啡因能够有效缩短呼吸机使用及吸氧时间,在一定程度上降低了BPD的发生率。

关键词: 布地奈德, 枸橼酸咖啡因, 支气管肺发育不良, 极低出生体重儿

Abstract: Objective To explore the clinical efficacy of early inhaled budesonide combined with caffeine citrate for preventing bronchopulmonary dysplasia(BPD) in very low birth weight(VLBW) infants,in order to provide evidence for the prevention and treatment of BPD. Methods A total of 60 VLBW infants with gestational age under 32 weeks and weight under 1 500 g in Binhu Hospital of Southern District,the First Hospital of Hefei City were enrolled in this study from October 2014 to October 2017,and were randomly assigned into budesonide combined with caffeine group(n=30) and caffeine group(n=30).Duration of ventilation,duration of oxygen supplementation,duration of hospitalization,mortality,incidence of BPD and common complications between the two groups were compared. Results Compared with the caffeine group,budesonide combined with caffeine group had a shorter duration of ventilation and oxygen supplementation(t=2.09,Z=-2.36,P <0.05).The incidence of BPD in budesonide combined with caffeine group was lower than that in caffeine group,but the difference was not statistically significant(P＞0.05).There were no significant differences on the duration of hospitalization and the incidence of other common complications between the two groups(P>0.05). Conclusion Early inhaled budesonide combined with caffeine citrate can effectively shorten the duration of ventilation and oxygen supplementation,and can reduce the incidence of BPD to some extent.

Key words: budesonide, caffeine citrate, bronchopulmonary dysplasia, very low birth weight infants

中图分类号:

R722.6

陈萌萌, 温晓红, 黄金华, 孙亚伟. 布地奈德联合咖啡因预防早产儿支气管肺发育不良的疗效研究[J]. 中国儿童保健杂志, 2019, 27(10): 1124-1127.

CHEN Meng-Meng, WEN Xiao-hong, HUANG Jin-hua, SUN Ya-wei. Clinical efficacy of budesonide combined with caffeine citrate for preventing bronchopulmonary dysplasia in preterm infants[J]. journal1, 2019, 27(10): 1124-1127.

参考文献

[1] Vom Hove M,Prenzel F,Uhlig HH,et al.Pulmonary outcome in former preterm,very low birth weight children with bronchopulmonary dysplasia:a case-control follow-up at school age[J] .J Pediatr,2014,164:40-45.
[2] Patel RM,Leong T,Carlton DP,et al.Early caffeine therapy and clinical outcomes in extremely preterm infants[J] .J Perinatol,2013,33:134-140.
[3] Doyle LW,Ehrenkranz RA,Halliday HL.Early(<8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants[J] .Cochrane Database Syst Rev,2014,5:CD001146.
[4] Jobe AH,Bancalari E.Bronchopulmonary dysplasia[J] .Am J Respir Crit Care Med,2001,163(7):1723-1729.
[5] Dionne JM,Abitbol CL,Flynn JT.Hypertension in infancy:diagnosis,management and outcome[J] .Pediatr Nephrol,2012,27(1):17-32.
[6] Sinclair JC,Bottino M,Cowett RM.Interventions for prevention of neonatal hyperglycemia in very low birth weight infants[J] .Cochrane Database Syst Rev,2011,5(10):7615-7617.
[7] Skinner J.Diagnosis of patentductus arteriosus[J] .Semin Neonatol,2001,6(1):49-61.
[8] Müller MJ,Paul T,Seeliger S.Necrotizing enterocolitis in premature infants and newborns[J] .J Neonatal Perinatal Med,2016,9(3):233-242.
[9] 中华医学会儿科学分会新生儿学组,中华医学会中华儿科杂志编辑委员会.新生儿肺出血的诊断与治疗方案[J] .中华儿科杂志,2001,39(4):248.
[10] 邵肖梅,叶鸿瑁,丘小汕.实用新生儿学[M] .北京:人民卫生出版社,2011:395-398.
[11] Northway WHJR,Rosan RC,Porter DY.Pulmonary disease following respirator therapy of hyaline-membrane disease.Bronchopulmonary dysplasia[J] .N Engl J Med,1967,276(7):357-368.
[12] Baraldi E,Filippone M.Chronic lung disease after premature birth[J] .N Engl J Med,2007,357(19):1946-1955.
[13] Jobe AH.What is BPD in 2012 and what will BPD become[J] .Early Hum Dev,2012,88(Suppl 2):27-28.
[14] Doyle LW,Halliday HL,Ehrenkranz RA,et al.An update on the impact of postnatal systemic corticosteroids on mortality and cerebral palsy in preterm infants:effect modification by risk of bronchopulmonary dysplasia[J] .J Pediatr,2014,165(6):1258-1260.
[15] Watterberg K.Evidence-based neonatal pharmacotherapy:postnatal corticosteroids[J] .Clin Perinatol,2012,39(1):47-59.
[16] Doyle LW,Ehrenkranz RA,Halliday HL.Postnatal hydrocortisone for preventing or treating bronchopulmonary dysplasia in preterm infants:a systematic review[J] .Neonatology,2010,98(2):111-117.
[17] Lim G,Lee BS,Choi YS,et al.Delayed dexamethasone therapy and neurodevelopmental outcomes in preterm infants with bronchopulmonary dysplasia[J] .Pediatrics and Neonatology,2015,56(4):261-267.
[18] Ohlsson A,Calvert SA,Hosking M,et al.Randomized controlled trial of dexamethasone treatment in very low birth weight infants with ventilator dependent chronic lung disease[J] .Acta Paediatrica,1992,81(10):751-756.
[19] Gupt S,Prasanth K,Chen CM,et al.Postnatal corticosteroids for prevention and treatment of chronic lung disease in the preterm newborn[J] .Int J Pediatr,2012,2012:315642.
[20] Bassler D,Plavka R,Shinwell ES,et al.Early Inhaled Bud esonide for the Prevention of Bronchopulmonary Dysplasia[J] .New England Journal of Medicine,2015,373(16):1497-1506.
[21] Shah VS,Ohlsson A,Halliday HL,et al.Early administration of inhaled corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates[J] .Cochrane Database Syst Rew,2012,5:CD001969.
[22] Onland W,Offringa M,van Kaam A.Late(≥ 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants[J] .Cochrane Database Syst Rew,2012,4:CD002311.
[23] 潘静,陈名武,倪文泉,等.肺表面活性物质联合布地奈德预防极低出生体重儿支气管肺发育不良的疗效观[J] .中国当代儿科杂志,2017,19(2):137-141.
[24] Dugas MA.Fluticasone inhalation in moderate cases of bron chopulmonary dysplasia[J] .Pediatrics,2005,115(5):566-572.
[25] Yeh TF,Chen CM,Wu SY,et al.Intratracheal administration of budesonide/surfactant to prevent bronchopulmonary dysplasia[J] .Am J Respir Crit Care Med,2016,193(1):86-95.

布地奈德联合咖啡因预防早产儿支气管肺发育不良的疗效研究

Clinical efficacy of budesonide combined with caffeine citrate for preventing bronchopulmonary dysplasia in preterm infants

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

[1]	夏正龙, 宋燕燕. 支气管肺发育不良早产儿神经发育研究[J]. 中国儿童保健杂志, 2023, 31(4): 390-394.
[2]	李静兰, 孙文强, 朱雪萍. 早产儿支气管肺发育不良相关预测模型研究[J]. 中国儿童保健杂志, 2023, 31(4): 395-398.
[3]	王惠萍, 王莉, 高琼, 白铂亮, 马颖君. 极低出生体重坏死性小肠结肠炎患儿体格及神经发育的研究[J]. 中国儿童保健杂志, 2023, 31(1): 96-100.
[4]	林洁, 段山. 支气管肺发育不良基因表达调控异常研究进展[J]. 中国儿童保健杂志, 2022, 30(6): 627-631.
[5]	惠晓君, 齐玉敏, 王品, 陈克云, 王岩. 支气管肺发育不良患儿重组人β防御素-2、血管新生相关基因对血管生成的调控机制及与肺发育标志物相关性[J]. 中国儿童保健杂志, 2022, 30(3): 325-329.
[6]	陈祥菲, 曲书强. 生物标志物在支气管肺发育不良发生风险中的研究进展[J]. 中国儿童保健杂志, 2022, 30(2): 176-180.
[7]	李尚彬, 郝玲, 李娇, 孟金凤, 黄嘉瑜, 闫伟宸, 王杰, 任常军. 极低和超低出生体重儿颅内出血危险因素Meta分析[J]. 中国儿童保健杂志, 2022, 30(2): 184-188.
[8]	高瑞, 李丛, 高玲玲, 韩梅盈, 许平. 极低出生体重儿和/或胎龄小于32周早产儿入院低体温发生的危险因素分析[J]. 中国儿童保健杂志, 2022, 30(2): 199-202.
[9]	游芳, 孔庆平, 强光峰, 赵静, 任雪云. 维生素D水平与极低出生体重儿临床结局的相关性研究[J]. 中国儿童保健杂志, 2022, 30(2): 216-220.
[10]	徐儒政, 孙斌. 动态分析生长发育迟缓与支气管肺发育不良严重程度的关系[J]. 中国儿童保健杂志, 2021, 29(6): 660-664.
[11]	董梦园, 吉玲, 刘萌萌, 朱逍帆, 王慧娟. 呼吸窘迫综合征早产儿发生支气管肺发育不良的危险因素分析[J]. 中国儿童保健杂志, 2021, 29(6): 685-688.
[12]	李倩倩, 姜泓. 维生素A与新生儿呼吸系统疾病关系的研究进展[J]. 中国儿童保健杂志, 2021, 29(5): 523-526.
[13]	彭倩, 曲书强. 肺微生物群落对早产儿肺发育影响的研究进展[J]. 中国儿童保健杂志, 2021, 29(3): 289-291.
[14]	王雪芹, 何婧, 何敏, 肖义维. 父母参与发展性照顾联合袋鼠式干预对极低出生体重儿生长发育、神经行为及胃饥饿素水平的影响[J]. 中国儿童保健杂志, 2021, 29(3): 313-317.
[15]	纪卫华, 王金元, 刁敬军. 血小板相关参数与早产儿中重度支气管肺发育不良关系研究[J]. 中国儿童保健杂志, 2021, 29(3): 323-327.